Clincosm LogoSign in Get a demo

Acute Lymphocytic Leukemia

Showing 51 - 75 of 102
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (EPZ-5676)

Completed
  • Leukemia
  • +3 more
  • Los Angeles, California
  • +8 more
May 7, 2020

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Houston (INCB018424)

Completed
Has Results
  • Acute Myeloid Leukemia
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 5, 2020

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (DFP-10917)

Completed
  • Acute Myeloid Leukemia
  • Acute Lymphocytic Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Oct 23, 2019

Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Everolimus (RAD001), Cyclophosphamide, Vincristine)

Completed
Has Results
  • Leukemia
  • Acute Lymphocytic Leukemia
  • Everolimus (RAD001)
  • +9 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 5, 2019

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (iTreg)

Completed
  • Acute Myelogenous Leukemia
  • +7 more
  • iTreg
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 17, 2019

Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia, Acute Myelocytic Leukemia Trial run by the NHLBI (Isolex 300i Stem Cell

Completed
  • Acute Lymphocytic Leukemia
  • +4 more
  • Isolex 300i Stem Cell Selection
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 25, 2018

CML (Chronic Myelogenous Leukemia), CLL (Chronic Lymphocytic Leukemia), AML (Acute Myelogenous Leukemia) Trial run by the NHLBI

Completed
Has Results
  • CML (Chronic Myelogenous Leukemia)
  • +4 more
  • Miltenyi system
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 14, 2018

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in New York (device, drug, procedure)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • +4 more
  • CliniMACS® CD34 Reagent System
  • +5 more
  • New York, New York
    Weill Cornell Medical College
Jun 12, 2018

Leukemia, Acute Lymphocytic Leukemia Trial in Stanford (Velcade)

Withdrawn
  • Leukemia
  • Acute Lymphocytic Leukemia
  • Stanford, California
    Stanford University School of Medicine
May 16, 2018

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Disorders Trial in Canada, United States (Clofarabine,

Terminated
  • Myelodysplastic Syndrome
  • +9 more
  • Phoenix, Arizona
  • +6 more
Feb 13, 2018

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Columbus (atorvastatin, Tacrolimus,

Completed
Has Results
  • Acute Myelogenous Leukemia
  • +2 more
  • Columbus, Ohio
    Ohio State University
Jan 16, 2018

Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Chronic Myelocytic Leukemia Trial in New York (ON 01910.Na)

Completed
  • Acute Myelocytic Leukemia
  • +4 more
  • ON 01910.Na
  • New York, New York
    Mount Sinai Medical Center
Jan 9, 2018

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (Unmanipulated UCB, SR-1

Withdrawn
  • Acute Myeloid Leukemia
  • +3 more
  • Unmanipulated UCB
  • SR-1 UCB
  • Minneapolis, Minnesota
    University of Minnesota Cancer Center
Dec 3, 2017

Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Minneapolis (biological, drug, radiation)

Withdrawn
  • Hematologic Malignancy
  • +16 more
  • Treg cells
  • +5 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 29, 2017

Leukemia, Acute Leukemia, Acute Lymphocytic Leukemia Trial in Hackensack, New York, Chapel Hill (Writing A (Experimental

Completed
  • Leukemia
  • +5 more
  • Writing A (Experimental informative writing)
  • +3 more
  • Hackensack, New Jersey
  • +2 more
Nov 14, 2017

Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Myeloproliferative Disease Trial in Houston (rigosertib)

Completed
  • Acute Myelocytic Leukemia
  • +3 more
  • Houston, Texas
    University of Texas M. D. Anderson Cancer Center
Jun 22, 2017

Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Lymphoma Trial in Dongguan, Foshan, Guangzhou (Drugs and anti-CD19 CAR

Unknown status
  • Acute Lymphocytic Leukemia
  • +2 more
  • Drugs and anti-CD19 CAR transduced T cells
  • Dongguan, Guangdong, China
  • +4 more
Jun 17, 2017

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplasia Trial in Memphis (drug, device, procedure)

Completed
Has Results
  • Acute Myeloid Leukemia
  • +4 more
  • Chemotherapy and antibodies
  • +2 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
May 25, 2017

Transfusional Iron Overload Among Leukemia Survivors

Completed
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    May 15, 2017

    Acute Lymphocytic Leukemia Trial in United States (Inotuzumab Ozogamicin)

    Completed
    Has Results
    • Acute Lymphocytic Leukemia
    • Inotuzumab Ozogamicin
    • Duarte, California
    • +14 more
    Mar 2, 2017

    Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Suzhou (anti-CD19 CAR-NK cells)

    Unknown status
    • Acute Lymphocytic Leukemia
    • +5 more
    • anti-CD19 CAR-NK cells
    • Suzhou, Jiangsu, China
      PersonGen BioTherapeutics (Suzhou) Co., Ltd.
    Dec 4, 2016

    Acute Myeloid Leukemia, MDS, Biphenotypic Leukemia Trial in Philadelphia (radiation, biological, drug, device)

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • +9 more
    • Total Body Irradiation (TBI)
    • +5 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Oct 19, 2016

    Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Suzhou (PCAR-019 (anti-CD19 CAR-T cells))

    Unknown status
    • Acute Lymphocytic Leukemia
    • +5 more
    • PCAR-019 (anti-CD19 CAR-T cells)
    • Suzhou, Jiangsu, China
      PersonGen BioTherapeutics (Suzhou) Co., Ltd.
    Oct 23, 2016

    Chronic Lymphocytic Leukemia, Acute Lymphocytic Leukemia, Lymphoma Trial in Shenzhen (Fludarabine, Cyclophosphamide,

    Unknown status
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital, The First Affiliated Hospital
    Aug 1, 2016

    Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Suzhou (PCAR-019 (anti-CD19 CAR-T cells))

    Unknown status
    • Acute Lymphocytic Leukemia
    • +5 more
    • PCAR-019 (anti-CD19 CAR-T cells)
    • Suzhou, Jiangsu, China
      PersonGen BioTherapeutics (Suzhou) Co., Ltd.
    Jul 28, 2016